HIV prevention drug hailed as breakthrough, but who gets access? Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.Share this: It’s the ‘closest thing to an HIV vaccine’, but who gets access?DateSeptember 30, 2026In relation toAl-JazeeraUS funding cuts deal blow to global HIV treatment: ReportDateJuly 21, 2026In relation toAl-JazeeraWhy is Pakistan’s Sindh province facing a major child HIV outbreak?DateJuly 17, 2026In relation toAl-Jazeera